Syntara Limited has released a press release.
US FDA Accepts Bronchitol New Drug Application for Review
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Syntara
Later from Syntara
- Appendix 4C - quarterly March 2016
- Pharmaxis Completes Recruitment of CF Clinical Trial for US
- Pharmaxis Announces Russian Approval for Bronchitol
- S&P DJ Indicies Announces March Quarterly Rebalance
- Research Collaboration with Woolcock Institute
Follow Syntara into a list and get an email when it puts out news.
Follow Syntara